Characterization of Specific Opioid Binding Sites in Neural Membranes from the Myenteric Plexus of Porcine Small Intestine
Open Access
- 1 January 2004
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 308 (1) , 385-393
- https://doi.org/10.1124/jpet.103.058016
Abstract
δ- and κ-Opioid receptors (OPRs), but not μ-OPRs, are expressed in the myenteric plexus of the porcine distal small intestine. In a subpopulation of myenteric neurons, δ- and κ-OPRs seem to be colocalized and may functionally interact. In this study, radioligand binding was used to characterize myenteric OPR populations in detail. The nonselective OPR antagonist [3H]diprenorphine bound to a single, high-affinity site in myenteric neural membrane homogenates. Naloxone displaced 65 and 59% of [3H]diprenorphine binding from this site in Na+-free Tris and Krebs-HEPES buffers, respectively. Naltrexone-derived δ- and κ-OPR antagonists, including naltriben, 7-benzylidenenaltrexone, nor-binaltorphimine, and 5′-guanidinonaltrindole, displaced [3H]diprenorphine from two distinct binding sites to levels similar to that of naloxone. The selective δ-OPR ligands Tyr-1,2,3,4-tetrahydroisoquinoline-Phe-Phe-OH (TIPP), [d-Pen2,d-Pen5]enkephalin (DPDPE), [d-Ala2, Glu4]deltorphin II, and (+)-4-[(αR)-α((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl-3-methoxybenzyl)-N,N-diethylbenzamide (SNC-80) and the κ-OPR agonist (d-(5α,7α,8β)-(-)-N-methyl-N-(7-(1-pyrrolidinyl)-1-oxoaspiro-(4,5)dec-8-yl) benzeneacetamide (U-69,593) displaced [3H]diprenorphine from three independent binding sites; these included high-affinity δ- and κ-OPR sites, and a residual binding site. Residual [3H]diprenorphine binding was displaced by the selective κ-OPR antagonist nor-binaltorphimine after saturation of δ and κ sites, respectively, with DPDPE and U-69,593. The residual binding site displayed low affinity for δ- and κ-OPR agonists and TIPP, as well as moderate affinity for naltrexone-derived ligands, properties reminiscent of δ-/κ-OPR heterodimers.This publication has 29 references indexed in Scilit:
- Presynaptic localization of the carboxy-terminus epitopes of the μ opioid receptor splice variants MOR-1C and MOR-1D in the superficial laminae of the rat spinal cordNeuroscience, 2001
- 5′-Guanidinonaltrindole, a highly selective and potent κ-opioid receptor antagonistEuropean Journal of Pharmacology, 2000
- 3D modeling, ligand binding and activation studies of the cloned mouse δ, μ and κ opioid receptorsProtein Engineering, Design and Selection, 1999
- G-protein-coupled receptor heterodimerization modulates receptor functionNature, 1999
- THE ENTERIC NERVOUS SYSTEM AND REGULATION OF INTESTINAL MOTILITYAnnual Review of Physiology, 1999
- Mutational Evidence for a Common κ Antagonist Binding Pocket in the Wild-Type κ and Mutant μ[K303E] Opioid ReceptorsJournal of Medicinal Chemistry, 1998
- Delta-Opioid Receptor mRNA Expression and Immunohistochemical Localization in Porcine IleumDigestive Diseases and Sciences, 1998
- B‐50 (GAP‐43): Biochemistry and Functional Neurochemistry of a Neuron‐Specific PhosphoproteinJournal of Neurochemistry, 1991
- In Vitro Models in the Study of Structure-Activity Relationships of Narcotic AnalgesicsAnnual Review of Pharmacology, 1975
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973